Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in Scotland

Data Availability

Data for this study (ID 2223-0033) are held by the National Services Scotland electronic Data Research and Innovation Service in the National Safe Haven. Restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data would be made available from a reasonable request to phs.edris{at}phs.scot.